Skip to main content

Table 1 Patient disease, staging and treatment (N = 248)

From: Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer

Diagnosis number of patient (%)
 Lymphoma 43 (17.7) Gastric cancer 9 (3.6)
 Hepatobiliary cancer 38 (15.3) Soft tissue sarcoma 9 (3.6)
 Lung cancer 27 (10.9) Bone cancer 8 (3.2)
 Colon & rectal cancer 27 (10.9) Bladder cancer 4 (1.5)
 Head and neck cancer 21 (8.4) Prostate cancer 3 (1.2)
 Breast cancer 20 (8) Testicular cancer 2 (0.8)
 Multiple myeloma 17 (6.9) Esophageal cancer 2 (0.8)
 Leukemia 10 (4) Othera 8 (3.2)
Stage of disease (%)
 Stage 1 6 (2.4)
 Stage 2 26 (10.1)
 Stage 3 45 (18.2)
 Stage 4 123 (49.6)
 Relapse 38 (15.3)
 Not relevant 10 (4.4)
Treatment (%)
 Chemotherapy 241 (97.2)
 CCRT 5 (2.0)
 Surgery 1 (0.4)
 Radiation 1 (0.4)
  1. aOther includes ovary, uterus, anal, CNS, pancreas, peritoneal, and unknown primary cancer
  2. CRRT Concurrent Chemotherapy and radiation